For patients with ovarian cancer, Li et al. developed a scoring system for fibrinogen and albumin aberrations and described elevated fibrinogen and decreased albumin levels to be associated with poor prognosis in patients undergoing primary cytoreductive surgery [19]. This evidence concerns the gene ALB and ovarian carcinoma.